Press-release for stocks for abbvie inc.

Ironwood Pharmaceuticals Reports Third Quarter 2023 Results
Published: 2023-11-09 (Crawled : 13:30) - biospace.com/
ABBV | News | $169.54 0.98% -0.91% 4.1M

Health Technology

| 16.92% | O: -1.81% H: 0.43% C: -2.1%
IRWD | $8.305 3.04% 2.95% 2.1M

Health Technology

| -12.68% | O: 2.93% H: 4.37% C: 0.21%
pharmaceuticals ironwood results

Advanced Anesthesia Devices and Ambulatory Surgical Centers Propel Growth in the US Anesthesia Market
Published: 2023-11-07 (Crawled : 00:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K

Health Technology

| 10.76% | O: -1.99% H: 1.92% C: 1.89%
TFX | $211.11 1.85% 0.2% 280K

Health Technology

| 1.2% | O: 0.92% H: 0.39% C: -3.0%
KKR | $97.97 3.71% 0.0% 3M

Finance

| 51.54% | O: 0.43% H: 0.28% C: -0.32%
GE | News | $162.62 8.28% 0.22% 19M

Electronic Technology

| 34.34% | O: 0.36% H: 1.65% C: 1.47%
BDX | $234.36 0.21% 0.0% 800K

Health Technology

| -8.68% | O: 0.57% H: 0.0% C: -0.64%
BAX | $41.02 1.54% 0.0% 2.6M

Health Technology

| 18.09% | O: 0.73% H: 0.0% C: -1.19%
ABBV | News | $169.54 0.98% -0.91% 4.1M

Health Technology

| 18.73% | O: 1.55% H: 0.0% C: 0.0%
ABT | News | $107.59 0.49% -0.09% 3.8M

Health Technology

| 12.49% | O: 0.04% H: 0.54% C: -0.5%
MMM | $93.0 0.41% -0.4% 3.7M

Producer Manufacturing

| -0.57% | O: 0.27% H: 0.0% C: -1.16%
ICUI | $97.82 1.49% 1.47% 160K

Health Technology

| 14.28% | O: -1.4% H: 4.7% C: 4.21%
AZN | News | $70.85 1.03% 1.02% 5.6M

Health Technology

| 10.25% | O: 0.25% H: 0.64% C: -0.38%
propel growth market

Genmab Announces Financial Results for the First Nine Months of 2023
Published: 2023-11-07 (Crawled : 16:00) - globenewswire.com
GNMSF | News | $289.67 3.83% 5.3K

Health Technology

| 1.53% | O: 0.39% H: 4.92% C: 1.52%
NVS | News | $97.28 2.27% 0.31% 3.7M

Health Technology

| 1.41% | O: 0.24% H: 0.18% C: 0.16%
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| -1.68% | O: 0.18% H: 0.0% C: 0.0%
ABBV | News | $169.54 0.98% -0.91% 4.1M

Health Technology

| 18.4% | O: -0.28% H: 0.0% C: 0.0%
GMAB | News | $28.54 -1.48% -1.51% 560K

Health Technology

| 0.42% | O: 0.24% H: 3.44% C: 2.07%
BNTX | News | $88.53 0.59% 0.59% 360K

Health Technology

| -11.73% | O: -0.35% H: 3.09% C: 3.03%
financial results

Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2023
Published: 2023-11-07 (Crawled : 15:00) - biospace.com/
ABBV | News | $169.54 0.98% -0.91% 4.1M

Health Technology

| 18.4% | O: -0.28% H: 0.0% C: 0.0%
SMMT | $3.72 6.59% 6.18% 1.8M

Health Technology

| 60.09% | O: -0.46% H: 6.68% C: -11.75%
PLSE | $6.86 0.15% 0.15% 120K

Health Technology

| 31.98% | O: 0.39% H: 6.43% C: 1.92%
BIIB | $193.18 -0.48% -0.48% 1.4M

Health Technology

| -21.93% | O: -0.82% H: 0.73% C: -0.4%
ALNY | $146.06 0.19% 0.18% 540K

Health Technology

| -12.78% | O: 1.06% H: 2.42% C: 0.76%
therapeutics financial results

Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights
Published: 2023-11-06 (Crawled : 21:00) - globenewswire.com
ABBV | News | $169.54 0.98% -0.91% 4.1M

Health Technology

| 18.4% | O: -0.28% H: 0.0% C: 0.0%
CHRS | $2.19 0.46% 0.46% 810K

Health Technology

| -38.42% | O: -22.6% H: 3.28% C: -9.85%
business financial results

Global Thyroid Gland Disorder Treatment Market Set to Reach USD 3.15 Billion by 2030, Reveals Infinium Global Research
Published: 2023-11-03 (Crawled : 09:00) - prnewswire.com
NVSEF | News | $95.11 6.88% 490

Health Technology

| 1.99% | O: -1.88% H: 3.51% C: 2.73%
NVS | News | $97.28 2.27% 0.31% 3.7M

Health Technology

| 0.73% | O: -1.4% H: 0.42% C: 0.0%
ABBV | News | $169.54 0.98% -0.91% 4.1M

Health Technology

| 18.87% | O: 1.88% H: 0.0% C: 0.0%
ABT | News | $107.59 0.49% -0.09% 3.8M

Health Technology

| 12.6% | O: 2.0% H: 0.0% C: 0.0%
reach treatment thyroid research global set market

Key Players Such as AbbVie, Roche, and Amgen Dominate the Competitive Landscape of the Expanding Cytokine Market
Published: 2023-11-03 (Crawled : 01:00) - prnewswire.com
UCBJF | $128.725 -39.66% 750

Health Technology

| 71.51% | O: -1.4% H: 0.0% C: 0.0%
UCBJY | $64.93 -4.38% 6.2K

Manufacturing

| 77.21% | O: 0.48% H: 1.02% C: 0.42%
TMO | News | $574.59 4.78% -1.12% 2.5M

Health Technology

| 23.4% | O: 2.32% H: 0.0% C: 0.0%
ABBV | News | $169.54 0.98% -0.91% 4.1M

Health Technology

| 18.87% | O: 1.88% H: 0.0% C: 0.0%
TECH | $63.675 1.39% 1.37% 1.2M

Health Technology

| 13.34% | O: 2.71% H: 4.38% C: 3.18%
AMGN | News | $273.69 0.66% 0.65% 2.5M

Health Technology

| 2.0% | O: 0.72% H: 0.76% C: 0.5%
ABCM | News | $23.99 0.0% 7.4M

Health Technology

| 3.63% | O: 0.0% H: 0.0% C: 0.0%
market

Kadcyla Leads the Global Antibody Drug Conjugates Market with Extensive Use in Breast Cancer Treatment
Published: 2023-11-01 (Crawled : 18:00) - prnewswire.com
ALPMY | News | $9.53 -1.11% 690K

Manufacturing

| -21.62% | O: -1.46% H: 3.67% C: 3.26%
ZYME | $8.56 -1.72% -1.75% 340K

Health Technology

| 24.07% | O: 1.14% H: 0.42% C: -0.7%
TAK | News | $13.38 0.15% 0.9% 1.7M

Health Technology

| -2.12% | O: 1.03% H: 0.73% C: 0.58%
ADCT | $4.97 6.2% 2.21% 400K

Health Technology

| 597.36% | O: -0.16% H: 6.42% C: 4.49%
ABBV | News | $169.54 0.98% -0.91% 4.1M

Health Technology

| 17.84% | O: -0.86% H: 0.0% C: 0.0%
STRO | $3.73 -1.06% -1.07% 720K

Health Technology

| 46.12% | O: 0.39% H: 3.86% C: 3.86%
IMGN | News | $31.23 0.03% 49M

Health Technology

| 109.1% | O: 5.09% H: 5.48% C: -1.27%
GILD | $67.03 0.12% 0.12% 5.2M

Health Technology

| -16.51% | O: -0.47% H: 1.88% C: 1.78%
EXEL | $23.295 1.86% 1.82% 1.9M

Health Technology

| 8.8% | O: -2.62% H: 1.17% C: -1.66%
drug antibody breast cancer treatment global market

Aldeyra Therapeutics Enters into Exclusive Option Agreement with AbbVie for License to Develop and Commercialize Reproxalap
Published: 2023-11-01 (Crawled : 12:00) - biospace.com/
ABBV | News | $169.54 0.98% -0.91% 4.1M

Health Technology

| 18.42% | O: 0.06% H: 1.3% C: 0.43%
ALDX | $3.91 -0.51% -0.51% 450K

Health Technology

| 129.82% | O: 16.96% H: 36.5% C: 27.0%
reproxalap abbvie license therapeutics agreement

Biosimilars market size to increase by USD 42.22 billion | The regulatory landscape regarding therapeutic interchangeability across different countries is the market trend - Technavio
Published: 2023-11-01 (Crawled : 09:00) - prnewswire.com
ABBV | News | $169.54 0.98% -0.91% 4.1M

Health Technology

| 18.42% | O: 0.06% H: 1.3% C: 0.43%
BIIB | $193.18 -0.48% -0.48% 1.4M

Health Technology

| -18.28% | O: 0.43% H: 1.05% C: 0.44%
AMGN | News | $273.69 0.66% 0.65% 2.5M

Health Technology

| 6.34% | O: 0.22% H: 1.92% C: 1.78%
market

Natural Skin Care Products Market is to grow by USD 4.77 billion from 2023 to 2028- Technavio
Published: 2023-10-31 (Crawled : 00:00) - prnewswire.com
UNLYF | $47.6 1.3% 1.4K

Consumer Non-Durables

| 4.34% | O: 3.14% H: 0.0% C: 0.0%
UL | $47.98 -0.17% -0.02% 2.7M

Consumer Non-Durables

| 1.5% | O: 0.27% H: 0.06% C: -0.57%
AMCR | $8.98 -0.55% 0.0% 5.6M

Process Industries

| 1.57% | O: 1.01% H: 1.06% C: -3.01%
ABBV | News | $169.54 0.98% -0.91% 4.1M

Health Technology

| 18.42% | O: 0.06% H: 1.3% C: 0.43%
natural care skin market

Breast Implant Market to grow by USD 588.1 million from 2022 to 2027, North America to account for 43% of market growth- Technavio
Published: 2023-10-30 (Crawled : 23:00) - prnewswire.com
ABBV | News | $169.54 0.98% -0.91% 4.1M

Health Technology

| 18.6% | O: 0.14% H: 0.0% C: 0.0%
ESTA | $49.78 3.13% 3.03% 270K

Health Technology

| 52.51% | O: -1.01% H: 0.38% C: -6.54%
CLGN | $5.28 0.38% 0.38% 13K

Health Technology

| 3.71% | O: -1.42% H: 7.0% C: 7.0%
america breast implant market

NEXGEL Secures Supply Agreement with AbbVie
Published: 2023-10-30 (Crawled : 12:00) - globenewswire.com
NXGL | $2.18 4.41% 1.4K

Manufacturing

| 36.25% | O: 5.0% H: 12.49% C: -4.76%
ABBV | News | $169.54 0.98% -0.91% 4.1M

Health Technology

| 22.0% | O: 2.87% H: 0.0% C: 0.0%
abbvie agreement

Anti-inflammatory Therapeutics Market Size to Hit US$ 149.5 billion by 2031 | Exclusive Study by Transparency Market Research
Published: 2023-10-30 (Crawled : 09:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630

Health Technology

| 12.78% | O: -4.67% H: 4.9% C: 4.9%
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| 7.64% | O: 2.76% H: 0.0% C: 0.0%
PFE | News 4 | $26.32 0.23% 0.0% 24M

Health Technology

| -12.79% | O: 0.43% H: 1.46% C: 1.03%
NVS | News | $97.28 2.27% 0.31% 3.7M

Health Technology

| 2.71% | O: 1.69% H: 0.25% C: -0.07%
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| 0.66% | O: -1.39% H: 0.79% C: 0.64%
GSK | News | $41.24 1.6% 0.0% 2.3M

Health Technology

| 17.45% | O: 2.29% H: 0.44% C: -0.23%
ABBV | News | $169.54 0.98% -0.91% 4.1M

Health Technology

| 22.0% | O: 2.87% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| 3.34% | O: -0.85% H: 0.0% C: 0.0%
research therapeutics study market

Piramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2024
Published: 2023-10-28 (Crawled : 12:20) - prnewswire.com
ABBV | News | $169.54 0.98% -0.91% 4.1M

Health Technology

| Email alert Add to watchlist
fy2024 pharma results